Rocket Pharmaceuticals (RCKT) said Wednesday that it has priced an upsized public offering of 13.2 million shares at $12.50 each, expected to raise $165 million in gross proceeds.
The company said the offering, slated to close around Thursday, includes a 30-day option for underwriters to purchase an additional 1.98 million shares.
Shares of the company were down 6% in recent Wednesday premarket activity.
Price: 12.71, Change: -0.80, Percent Change: -5.92
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。